Generalized efficacy of rt-PA for acute stroke: subgroup analysis of the NINDS rt-PA Stroke Trial. Stroke. 1997;28:2119-2124.The NINDS t-PA Stroke Study Group. Generalized efficacy of t- PA for acute stroke: subgroup analysis of the NINDS t-PA stroke trial. Stroke 1997;28:2119-2125...
Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke. Stroke 1993; 24: 1000–1004. CrossRef NINDS rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581–1587. Kwiatkowski TG, Libman RB, Frankel M, Tilley ...
Hypertension and its treatment in the NINDS rt-PA Stroke Trial (see comments) BACKGROUND AND PURPOSE: We examined the frequency, course, and treatment of hypertension in the NINDS rt-PA Stroke Trial. METHODS: Blood pressure (BP) was ... T Brott,M Lu,R Kothari,... - 《Stroke A Journal...
The 4,249 African Americans enrolled constituted 21.1% of the trial population, which declined to 13.3% when the one race specific trial was excluded. African American enrollment increased by time period (12.1% before 1995, 16.0% after, p < 0.001). Hispanic ethnicity was reported in 22.7% (...
Reliability of the Barthel Index Outcome Measure selected for the NINDS t-PA Stroke Trial. Thrombolytic Therapy in Acute Ischemic Stroke III. Tokyo: Springer-Verlag;1995:327.Lyden P, Broderick J, Mascha E, Group Nr-PSS, Yamaguchi T, Mori E, et al. Reliability of the Barthel Index outcome ...